Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

NCT00046137 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: teriparatide
DRUG: raloxifene
DRUG: placebo

Sponsor

Eli Lilly and Company